Colorado’s MedPharm Clears Significant DEA Hurdle For Federal Cannabis Research License

MedPharm researcher

COLORADO: MedPharm Research, the leader in cannabis research and formulation development, was notified by the Drug Enforcement Administration (DEA) that it had been selected to move forward as one of the first applicants to be granted a license to grow federally legal cannabis under the terms of a new policy statement issued today in the Federal Read the full article…

DEA Announces Steps Necessary To Improve Access To Marijuana Research

DEA Badge

DISTRICT OF COLUMBIA: The Drug Enforcement Administration today announced that it is moving forward to facilitate and expand scientific and medical research for marijuana in the United States. The DEA is providing notice of pending applications from entities applying to be registered to manufacture marijuana for researchers. DEA anticipates that registering additional qualified marijuana growers Read the full article…

US Attorney General Jeff Sessions Resigns

Jeff Sessions is Fired

DISTRICT OF COLUMBIA: United States Attorney General Jeff Sessions on Wednesday announced his resignation from the Justice Department. Sessions was a longstanding, vocal opponent of marijuana policy reform, who once opined, “Good people don’t smoke marijuana.” As Attorney General, his office rescinded the 2013 Cole memorandum which directed prosecutors not to interfere in state-sanctioned marijuana activity. However, that action encouraged numerous Read the full article…

Tilray Gets DEA OK To Import Medical Cannabis Study Drug For Clinical Trial At University Of California San Diego Center For Medicinal Cannabis Research

r7_essentialtremor-8col

CANADA: Tilray has announced that the U.S. Drug Enforcement Administration (DEA) has granted approval to import a cannabinoid study drug into the United States from Canada for a clinical trial at the University of California San Diego (UC San Diego) Center for Medicinal Cannabis Research (CMCR) examining its safety, tolerability and efficacy for Essential Tremor (ET). Read the full article…

Statement From FDA Commissioner Scott Gottlieb On Researching Medical Uses Of Cannabis

Statement by FDA Commissioner Scott Gottlieb, M.D., on the importance of conducting proper research to prove safe and effective medical uses for the active chemicals in marijuana and its components

By Scott Gottlieb, MD DISTRICT OF COLUMBIA: Over the past decade, we’ve seen a growing interest in the development of therapies derived from marijuana and its components. Proponents of “medical marijuana” advertised its uses for a wide number of medical conditions, such as cancer, multiple sclerosis, post-traumatic stress disorder and anxiety – just to name Read the full article…

DEA: Marijuana Seizures Fell Nearly 40 Percent In 2017

The agency and its partners reported making 4,502 arrests in conjunction with their cannabis eradication efforts - a 20 percent decline from 2016.

DISTRICT OF COLUMBIA: Seizures of indoor and outdoor cannabis crops in the United States fell nearly 40 percent between 2016 and 2017, according to annual data compiled by the US Drug Enforcement Administration. According to figures published in the DEA’s Domestic Cannabis Eradication/Suppression Statistical Report, the agency and its law enforcement partners confiscated an estimated 3.38 million marijuana Read the full article…

DEA Clarifies Stance: Not All CBD Is Prohibited

DEA Badge

Drug Enforcement Administration confirmed this month that CBD does not fall under the Controlled Substances Act CALIFORNIA: The Drug Enforcement Administration (DEA) has issued a statement further clarifying their interpretation and enforcement of the Controlled Substances Act (CSA). In their statement, they make clear the critical difference between CBD and THC, a distinction that cannabidiol retailers Read the full article…

Court Rejects Challenge To DEA’s Classification Of Marijuana Extracts

MJ_Legal

CALIFORNIA: A three judge panel for the Ninth Circuit Court of Appeals has denied a petition filed by the Hemp Industries Association challenging the DEA’s authority to establish a new administrative drug code specifically for marijuana extracts. The DEA first announced the proposed rule change in 2011, but did not enact the new policy until January 13, 2017. In a Read the full article…

Justice Department Issues Memo On Marijuana Enforcement

Justice Department Issues Memo on Marijuana Enforcement

DISTRICT OF COLUMBIA:  The Department of Justice today issued a memo on federal marijuana enforcement policy announcing a return to the rule of law and the rescission of previous guidance documents. Since the passage of the Controlled Substances Act (CSA) in 1970, Congress has generally prohibited the cultivation, distribution, and possession of marijuana. In the Read the full article…

U.S. Attorney Bob Troyer Issues Statement Regarding Marijuana Prosecutions in Colorado

MJ_Legal

COLORADO:  U.S. Attorney Bob Troyer of the District of Colorado has issued the following statement regarding marijuana prosecutions: “Today the Attorney General rescinded the Cole Memo on marijuana prosecutions, and directed that federal marijuana prosecution decisions be governed by the same principles that have long governed all of our prosecution decisions.  The United States Attorney’s Office Read the full article…